Cue Biopharma CUE
-
-
-
已收盤：-
淨值比明細
年季 | 收盤價 | 權益總計(百萬) | 稅後權益報酬率(%) | 稅後純益(百萬) | 稅後資產報酬率(%) | 資產總計(百萬) |
|---|---|---|---|---|---|---|
| 2026Q1 | 6.9 | 22 | -21.56 | -5 | -14.17 | 31 |
| 2025Q4 | 9.16 | 26 | 7.99 | 2 | 4.29 | 42 |
| 2025Q3 | 21.56 | 13 | -47.43 | -7 | -20.59 | 32 |
| 2025Q2 | 20.47 | 18 | -68.57 | -8 | -26.94 | 41 |
| 2025Q1 | 27.33 | 7 | -101.81 | -12 | -45.03 | 22 |
| 2024Q4 | 32.7 | 17 | -44.31 | -9 | -24.66 | 32 |
| 2024Q3 | 22.72 | 25 | -36.86 | -9 | -19.88 | 45 |
| 2024Q2 | 37.2 | 22 | -39.38 | -10 | -21.13 | 42 |
| 2024Q1 | 56.7 | 30 | -36.79 | -12 | -21.38 | 54 |
| 2023Q4 | 79.2 | 37 | -33.69 | -13 | -20.6 | 62 |
| 2023Q3 | 69 | 43 | -24.82 | -11 | -15.49 | 69 |
| 2023Q2 | 109.5 | 46 | -26.1 | -13 | -17.03 | 73 |
| 2023Q1 | 107.1 | 55 | -21.72 | -13 | -15.16 | 82 |
| 2022Q4 | 85.5 | 66 | -25.06 | -15 | -17.41 | 91 |
| 2022Q3 | 66.9 | 51 | -19.82 | -11 | -13.6 | 76 |
| 2022Q2 | 74.7 | 60 | -21.23 | -13 | -15.06 | 85 |
| 2022Q1 | 146.4 | 65 | -21.9 | -14 | -16.38 | 91 |
| 2021Q4 | 339.3 | 65 | -13 | -8 | -10.33 | 83 |
| 2021Q3 | 437.1 | 64 | -19.05 | -13 | -15.42 | 79 |
| 2021Q2 | 349.5 | 73 | -14.42 | -10 | -11.52 | 90 |